Skip to content

Clinical trials

Phase 4 Schizophrenia trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Phase 4 Country / region: South Korea Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20043
20052
20061
20072
20086
20091
20103
20112
20124
20171
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Terminated4
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Korea, Ltd., Korea8
Seoul National University Hospital4
Korea Otsuka Pharmaceutical Co., Ltd.3
Chonbuk National University Hospital2
Inje University2
AstraZeneca1
Chonnam National University Hospital1
Eli Lilly and Company1
Janssen Research & Development, LLC1
Ortho-McNeil Janssen Scientific Affairs, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia27
Psychotic Disorders4
Mental Disorders1
Metabolic Syndrome1
Obesity1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.